Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting
predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical …

Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune
haemolytic anaemia, thrombocytopenia, and acute renal failure, in which the underlying …

Background. Complement dysregulation occurs in thrombotic microangiopathies (TMAs)
other than primary atypical haemolytic uraemic syndrome (aHUS). A few of these patients …

Eculizumab has opened new horizons in the treatment of complement-mediated disorders.
Prophylactic and immunization strategies against the risk of Nesseria spp. infections are …

Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, progressive, life-threatening
form of thrombotic microangiopathy (TMA) predominantly caused by dysregulation of the …

Thrombotic microangiopathy (TMA) is a serious complication of transplantation that
adversely affects kidney transplant recipient and allograft survival. Post-transplant TMA is …

El síndrome hemolítico urémico (SHU) es una entidad clínica definida por la tríada anemia
hemolítica no inmune, trombocitopenia e insuficiencia renal aguda, en la que las lesiones …

Thrombotic microangiopathy is a rare but serious complication that affects kidney transplant
recipients. It appears in 0.8–14% of transplanted patients and negatively affects graft and …

Thrombotic microangiopathy (TMA) is one of the most devastating sequalae of kidney
transplantation. A number of published articles have covered either de novo or recurrent …